AT
SAGE icon

Arden Trust’s Sage Therapeutics SAGE Stock Holding History

Arden Trust’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-60
Closed -$2K – 668
2020
Q1 		$2K Buy
+60
New +$3.47K ﹤0.01% 698
2019
Q4 		– Sell
-1,525
Closed -$214K – 364
2019
Q3 		$214K Buy
1,525
+1
+0.1% +$167 0.03% 333
2019
Q2 		$279K Buy
1,524
+15
+1% +$2.56K 0.05% 281
2019
Q1 		$240K Buy
+1,509
New +$219K 0.04% 324

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Arden Trust's SAGE Position: Q2 2020 in Review

Arden Trust sold out of Sage Therapeutics (SAGE) in Q2 2020, closing a stake of 60 shares — an estimated $2K sold.

Arden Trust first reported a position in SAGE in Q1 2019 and held it in 4 quarters. The position peaked at $279K in Q2 2019. 217 funds tracked by Wall St. Rank hold SAGE as of Q2 2020.

  • Arden Trust reported no remaining Sage Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 60 Sage Therapeutics shares in Q2 2020, an estimated $2K.
  • Arden Trust first reported a position in Sage Therapeutics in Q1 2019 and held it in 4 quarters.
  • Arden Trust's Sage Therapeutics position peaked at $279K in Q2 2019.
  • 217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.